Skip to content

A randomized controlled clinical study for the role of hysterosalpingography and hysterosalpingocontrast sonography in pregnancy

A randomized controlled clinical study on the role for hysterosalpingography and hysterosalpingocontrast sonography in pregnancy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025866
Enrollment
Unknown
Registered
2019-09-11
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

1:OSCM HSG
2:HyCoSy

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 20-39 years; female; 2. Those who have normal sexual life and have not taken contraceptive measures to cohabit for more than one year without pregnancy; 3. FSH level in the early follicular phase was less than 10 IU/L, progesterone level in the middle luteal phase was more than 25 mmol/L. 4. Accord with the indication of hysterosalpingography; 5. Understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Contrast allergy is known; 2. Fewer than 8 menstrual cycles per year, or no ovulation cycle induction is effective; 3. Has received HSG or HyCoSy in the past year; 4. Fallopian tube obstruction is known; 5. Functional infertility of endometrium or ovary; 6. Pelvic infection or organ lesions; 7. Uterine bleeding (including menstruation); 8. The total number of motile sperm after husband's washing is less than 1 million/ml or that of non-washing motile sperm is less than 10 million/ml; 9. The patients with serious somatic diseases include tumors, cerebral infarction, brain trauma, encephalitis, liver and kidney failure, heart and lung failure, severe anemia and other blood diseases.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;

Secondary

MeasureTime frame
live birth rate;abortion;ectopic pregnancy;twins;pregnancy time after operation;

Countries

China

Contacts

Public ContactMingjin Cai

The Third Affiliated Hospital of Guangzhou Medical University

mingjincai@163.com+86 18928916687

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026